Butamben
As of the edition of 20 October 2026, Butamben is a small molecule: marketed, first approved in 1994 (CA); acts on TRPA1 and TRPV4.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1994
- Kind
- Small molecule
- Brand name
- Cetacaine
- First approved
- 31 December 1994 (CA)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Cetylite Industries
- Withdrawn from market
- 1 January 1964 (in some regions)
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Cetylite Industries | Applicant | 1994 to now |